Ticker
FATECompany Name
FATE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Operating Expenses |
---|---|
6/30/2025 | $ 200.84M |
3/31/2025 | $ 213.82M |
12/31/2024 | $ 223.91M |
9/30/2024 | $ 210.05M |
6/30/2024 | $ 207.82M |
3/31/2024 | $ 219.47M |
12/31/2023 | $ 254.04M |
9/30/2023 | $ 313.07M |
6/30/2023 | $ 361.22M |
3/31/2023 | $ 399.38M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Minimum
Sep 30, 2020
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 3.46K |
---|---|
min | $ -391.56M |
max | $ 1.16B |
average | $ 232.5M |
median | $ 120.21M |
std | $ 271.53M |